Daniel A. Haber - Publications

Massachusetts General Hospital Cancer Center Harvard Medical School, Boston, MA, United States 

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1999 Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (New York, N.Y.). 286: 2528-31. PMID 10617473 DOI: 10.1126/Science.286.5449.2528  0.44
1998 Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, ... ... Haber DA, et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proceedings of the National Academy of Sciences of the United States of America. 95: 13765-70. PMID 9811875 DOI: 10.1073/Pnas.95.23.13765  0.72
1998 Nichols KE, Li FP, Haber DA, Diller L. Childhood cancer predisposition: applications of molecular testing and future implications. The Journal of Pediatrics. 132: 389-97. PMID 9544888 DOI: 10.1016/S0022-3476(98)70007-1  0.44
1993 Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Demetri G, Griffin J, Minden M, Housman DE, Haber DA. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma Nature Genetics. 4: 415-420. PMID 8401592 DOI: 10.1038/ng0893-415  0.72
1993 Skare J, Wu B, Madan S, Pulijaal V, Purtilo D, Haber D, Nelson D, Sylla B, Grierson H, Nitowsky H, Glaser J, Wissink J, White B, Holden J, Housman D, et al. Characterization of three overlapping deletions causing X-linked lymphoproliferative disease Genomics. 16: 254-255. PMID 8387453 DOI: 10.1006/Geno.1993.1169  0.32
1992 Baird PN, Groves N, Haber DA, Housman DE, Cowell JK. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene. 7: 2141-9. PMID 1331933  0.72
1992 Haber DA, Housman DE. The genetics of Wilms' tumor. Advances in Cancer Research. 59: 41-68. PMID 1325734 DOI: 10.1016/S0065-230X(08)60302-4  0.72
1992 Haber DA, Housman DE. Role of the WT1 gene in Wilms' tumour. Cancer Surveys. 12: 105-17. PMID 1322241  0.72
1992 Haber DA, Timmers HT, Pelletier J, Sharp PA, Housman DE. A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells. Proceedings of the National Academy of Sciences of the United States of America. 89: 6010-4. PMID 1321431 DOI: 10.1073/Pnas.89.13.6010  0.72
1991 Cowell JK, Wadey RB, Haber DA, Call KM, Housman DE, Pritchard J. Structural rearrangements of the WT1 gene in Wilms' tumour cells. Oncogene. 6: 595-9. PMID 1851548  0.72
1991 Buckler AJ, Chang DD, Graw SL, Brook JD, Haber DA, Sharp PA, Housman DE. Exon amplification: a strategy to isolate mammalian genes based on RNA splicing. Proceedings of the National Academy of Sciences of the United States of America. 88: 4005-9. PMID 1850845 DOI: 10.1073/Pnas.88.9.4005  0.72
1991 Haber DA, Housman DE. Rate-limiting steps: the genetics of pediatric cancers. Cell. 64: 5-8. PMID 1846091 DOI: 10.1016/0092-8674(91)90200-I  0.72
1991 Huff V, Miwa H, Haber DA, Call KM, Housman D, Strong LC, Saunders GF. Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT. American Journal of Human Genetics. 48: 997-1003. PMID 1673293  0.4
1991 Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Molecular and Cellular Biology. 11: 1707-12. PMID 1671709 DOI: 10.1128/Mcb.11.3.1707  0.72
1991 Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proceedings of the National Academy of Sciences of the United States of America. 88: 9618-22. PMID 1658787 DOI: 10.1073/Pnas.88.21.9618  0.72
1991 Schwartz CE, Haber DA, Stanton VP, Strong LC, Skolnick MH, Housman DE. Familial predisposition to Wilms tumor does not segregate with the WT1 gene. Genomics. 10: 927-30. PMID 1655633 DOI: 10.1016/0888-7543(91)90181-D  0.72
1991 Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 67: 437-447. PMID 1655284 DOI: 10.1016/0092-8674(91)90194-4  0.44
1991 Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature. 353: 431-4. PMID 1654525 DOI: 10.1038/353431A0  0.72
1991 Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes & Development. 5: 1345-56. PMID 1651275 DOI: 10.1101/Gad.5.8.1345  0.44
1990 Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell. 61: 1257-69. PMID 2163761 DOI: 10.1016/0092-8674(90)90690-G  0.72
1989 Haber DA, Housman DE. MspI/HpaII polymorphism in the human multidrug resistance gene 1. Nucleic Acids Research. 17: 10142. PMID 2481261 DOI: 10.1093/Nar/17.23.10142  0.72
1989 Croop JM, Raymond M, Haber D, Devault A, Arceci RJ, Gros P, Housman DE. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Molecular and Cellular Biology. 9: 1346-50. PMID 2471060 DOI: 10.1128/Mcb.9.3.1346  0.72
1982 Haber DA, Schimke RT. Chromosome-mediated transfer and amplification of an altered mouse dihydrofolate reductase gene. Somatic Cell Genetics. 8: 499-508. PMID 7123452 DOI: 10.1007/Bf01538710  1
1981 Haber DA, Schimke RT. Unstable amplification of an altered dihydrofolate reductase gene associated with double-minute chromosomes. Cell. 26: 355-62. PMID 7326744 DOI: 10.1016/0092-8674(81)90204-X  1
1981 Haber DA, Beverley SM, Kiely ML, Schimke RT. Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. The Journal of Biological Chemistry. 256: 9501-10. PMID 7287696  1
Show low-probability matches.